Phathom Pharmaceuticals (PHAT) Shares Drop 18% Amid FDA Lawsuit Over Voquezna Generic Application

gurufocus.com · 2026-10-23

On October 23, 2026, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) saw its stock price decline sharply by 18% following a lawsuit filed by BDR Pharmaceuticals Inte

Read the full story at gurufocus.com →